SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2022 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 21, 2022, by and between PROPANC BIOPHARMA, INC,, a Delaware corporation, with headquarters located at 302, 6 Butler Street, Camberwell, VIC 3124 Australia (the “Company”), and GS CAPITAL PARNTERS, LLC, a Nevada limited liability company, with its address at 1 East Liberty Street, Suite 600, Reno, NV 85901 (the “Buyer”).
